In Vitro Activity of Various Sulbactam Compounds and Piperacillin/Tazobactam against Clinical Isolates of Different Gram-Negative Bacteria

To provide direction for clinical application and pharmaceutical exploitation, the in vitro activity of sulbactam compounds and PIP/TAZ 8 : 1 against clinical isolates of Gram-negative bacteria (GNB, n = 976) was evaluated according to Clinical and Laboratory Standards Institute (CLSI) 2019. By mini...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Shunian, Zhuo, Chuyue, Zhuo, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639252/
https://www.ncbi.nlm.nih.gov/pubmed/34868336
http://dx.doi.org/10.1155/2021/1175379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639252/
https://www.ncbi.nlm.nih.gov/pubmed/34868336
http://dx.doi.org/10.1155/2021/1175379

Ejemplares similares